
Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: October 2012
-
By Kevin E. Noonan — Since 1980, the Bayh-Dole Act has encouraged, facilitated, and required universities and other recipients of Federal grant money to license inventions resulting from funded research for commercialization. While this has been one of the bedrocks upon which the biotechnology industry was built, and has enabled almost every research university to…
-
By Donald Zuhn — USPTO Proposes Update to Code of Professional Responsibility Earlier this month, the U.S. Patent and Trademark Office announced its proposal to update the USPTO Code of Professional Responsibility to conform to the Model Rules of Professional Conduct of the American Bar Association (ABA). The Office's notice of proposed rulemaking, entitled "Changes…
-
By Donald Zuhn — Earlier this month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the third quarter of 2012. The report, which is prepared by NVCA and PriceWaterhouseCoopers LLP using data from Thomson Reuters, indicates that…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Inventor Compensation: A Global Approach Needed" on October 31, 2012 beginning at 2:00 pm (ET). A panel consisting of John Conway, Vice President and Global Head of Innovative Healthcare Patent Support at Sanofi; Donald Dowling of White & Case; and Matthew Penarczyk, Associate…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Biogen Idec MA Inc. v. Kappos1:12-cv-01171; filed October 19, 2012 in the Eastern District of Virginia Review and correction of the patent term adjustment calculation made by the U.S. Patent and Trademark Office for U.S.…
-
October 30, 2012 – Divided Patent Infringement: Protecting IP Rights — Strategies for Drafting and Prosecuting Claims and Allocating Liability (Strafford) – 1:00 – 2:30 pm (EDT) November 2, 2012 – IP Law Symposium (Intellectual Property Law Association of Chicago) – Chicago, IL November 12-14, 2012 – Fall Intellectual Property Counsels Committee (IPCC) Conference (Biotechnology…
-
Strafford will be offering a webinar/teleconference entitled "Patents and the Written Description Requirement: Navigating Section 112 Disclosure Obligations and Withstanding Invalidity Challenges" on November 27, 2012 from 1:00 – 2:30 pm (EST). Thomas L. Irving of Finnegan Henderson Farabow Garrett & Dunner will provide guidance for dealing with the U.S. Patent Law Section 112's written…
-
By Donald Zuhn — While the U.S. Food and Drug Administration recently noted that the agency "has been unable to reach a decision" on a Citizen Petition regarding the Biologics Price Competition and Innovation Act (BPCIA) filed by Abbott Laboratories last April, the same cannot be said of California Representative Anna Eshoo, who sent a…
-
By Donald Zuhn — In April, Abbott Laboratories filed a Citizen Petition with the U.S. Food and Drug Administration, asking the agency to refrain from accepting biosimilar applications under the Biologics Price Competition and Innovation Act (BPCIA) that cite reference products (biologics) for which a biologics license application (BLA) was submitted to the FDA prior…
-
By Donald Zuhn — Last month, the U.S. Patent and Trademark Office and European Patent Office announced the publication of an advanced version of the Cooperative Patent Classification (CPC) scheme and some final CPC definitions ahead of the CPC's official launch on January 1, 2013. The CPC is a detailed classification system that includes approximately…